Table 1.
Demographic and clinical data in the MSC and the control group at baseline, and 8 and 24 weeks
| No. | Group | Age, years/sex | Months after stroke | Lesion area all MCA territory | Lesion volume ml | CD90 % | CD73 % | CD105 % | Baseline |
8 weeks |
24 weeks |
|||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FM n/66 | mBI n/100 | FM n/66 | mBI n/100 | FM n/66 | mBI n/100 | |||||||||
| 1 | E | 28/F | 11 | R frontoparietal (I) | 12 | 40 | 40 | 44 | 22 | 52 | 36 | 72 | 44 | 80 |
| 2 | E | 20/F | 12 | R frontoparietal (H) | 58 | 52 | 58 | 38 | 11 | 30 | 22 | 42 | 30 | 60 |
| 3 | E | 59/F | 7 | R frontal (I) | 34.6 | 67 | 65 | 23 | 11 | 40 | 26 | 55 | 32 | 70 |
| 4 | E | 35/F | 8 | L internal capsule (H) | 13.5 | 45 | 43 | 48 | 14 | 32 | 20 | 53 | 28 | 65 |
| 5 | E | 55/M | 9 | R frontal (I) | 14.2 | 76 | 76 | 52 | 22 | 52 | 38 | 65 | 44 | 78 |
| 6 | E | 55/M | 8 | R frontal (I) | 15.1 | 86 | 61 | 35 | 20 | 58 | 32 | 70 | 42 | 82 |
| Mean | 42 | 9.3 | 24.5 | 61 | 57.1 | 40 | 16.6 | 44 | 29 | 59.5 | 36.6 | 72.5 | ||
| 1 | C | 40/M | 10 | L frontal (I) | 55 | _ | _ | _ | 11 | 40 | 20 | 55 | 30 | 65 |
| 2 | C | 28/M | 12 | R parietal (I) | 12.2 | − | − | − | 20 | 52 | 31 | 62 | 38 | 78 |
| 3 | C | 42/M | 8 | R internal capsule (I) | 15.4 | − | − | − | 12 | 35 | 26 | 52 | 36 | 65 |
| 4 | C | 30/M | 12 | L temporoparietal (I) | 45.5 | − | − | − | 11 | 42 | 20 | 50 | 30 | 68 |
| 5 | C | 60/M | 7 | L caudate (I) | 10 | − | − | − | 24 | 55 | 36 | 65 | 33 | 73 |
| 6 | C | 50/M | R frontoparietal (H) | 11.2 | − | − | − | 23 | 50 | 30 | 68 | 38 | 72 | |
| Mean | 46.5 | 9.3 | 24.8 | - | - | - | 16.8 | 45.6 | 27.1 | 58.6 | 34.1 | 70.1 | ||
C = Control; E = MSC; R = right; L = left; I = ischemia; H = hemorrhage.